Leipzig in focus: Europe's pioneers meet for the obesity conference!

Leipzig in focus: Europe's pioneers meet for the obesity conference!

Leipzig, Deutschland - The upcoming European Biopharma Obesity Infores Forum (EBIIF) will take place on June 11 and 12, 2025 in Leipzig. This international conference is part of the renowned Sachs forums and is aimed at representatives from science, pharmaceutical industry, healthcare industry, politics and investors. The aim of the event is to discuss new ways in dealing with obesity, whereby in particular innovative therapies, digital solutions and regulatory strategies are in the foreground.

The relevance of the topic is obvious: According to forecasts of the World Obesity Federation , the proportion of people with adipositas could be defined as a body-mass index from over 30, to Rise to 24% in 2035. In 2020 this value was still 14%. This would be about 1.9 billion people worldwide. The global costs for health care caused by overweight and obesity could reach up to $ 4.32 trillion per year, which exudes about 3% of the global gross domestic product.

research and innovation in focus

The event will attract approximately 150 experts from Asia, Europe and North America. The agenda includes keynote presentations on GLP-1-based therapies and its effects on metabolic care. In addition, panel discussions on current topics such as the market potential of obesity medication and the development of new medication will take place. Investors are also invited in a special panel to discuss financing and partnership options in the biotech industry. The focus is on obesity and metabolic diseases, which illustrates the urgency and complexity of the challenges with which this industry is faced.

Leonard Sachs, initiator of the conference, highlights the key role in Europe in research on metabolic diseases. Leipzig is often referred to as an emerging center for life sciences and medical research, equipped with excellent infrastructure and numerous renowned institutions such as the Fraunhofer Institute for Cell Therapy and Immunology (IZI) and the Biocity Campus. There are also dense networks of research institutions, including three Max Planck Institutes and two Fraunhofer Institutes.

important speakers and interactive sessions

The Keynote spokesman at the conference include well-known experts such as Dr. Andres Acosta, Prof. Antje Körner and Prof. Arya Sharma. The two -day presence event is supplemented by virtual sequels on June 18 and 19, which offers international participants the opportunity to get involved.

With a strong focus on innovative therapies, clinical developments and digital health solutions, the forum offers a valuable platform for start-ups, investors and established pharmaceutical companies to form partnerships and to address obesity pandemic. Further information and the possibility of registration can be found at www.sachsachsforum.com/1eboif-about.html